• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Advanced bladder cancer: the need to identify new agents in the post-M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) world.

作者信息

Roth B J, Bajorin D F

机构信息

Department of Medicine, Indiana University Medical Center, Indianapolis.

出版信息

J Urol. 1995 Mar;153(3 Pt 2):894-900.

PMID:7853569
Abstract
摘要

相似文献

1
Advanced bladder cancer: the need to identify new agents in the post-M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) world.
J Urol. 1995 Mar;153(3 Pt 2):894-900.
2
Chemotherapy for advanced bladder carcinoma: new molecules and regimens.
Acta Urol Belg. 1996 May;64(2):43-5.
3
New chemotherapy regimens for advanced bladder cancer.
Semin Urol Oncol. 1998 Feb;16(1):23-9.
4
New approaches to treatment of metastatic bladder cancer.转移性膀胱癌的新治疗方法。
Curr Oncol Rep. 2000 Sep;2(5):379-85. doi: 10.1007/s11912-000-0056-2.
5
Gemcitabine for unresectable, locally advanced or metastatic bladder cancer.吉西他滨用于不可切除的局部晚期或转移性膀胱癌。
Cochrane Database Syst Rev. 2011 Apr 13(4):CD008976. doi: 10.1002/14651858.CD008976.pub2.
6
Systemic chemotherapy of transitional cell carcinoma of the urothelium.尿路上皮移行细胞癌的全身化疗。
Semin Surg Oncol. 1997 Sep-Oct;13(5):365-75. doi: 10.1002/(sici)1098-2388(199709/10)13:5<365::aid-ssu11>3.0.co;2-m.
7
Neoadjuvant gemcitabine plus carboplatin for locally advanced bladder cancer.新辅助吉西他滨加卡铂治疗局部晚期膀胱癌。
Jpn J Clin Oncol. 2013 Feb;43(2):193-9. doi: 10.1093/jjco/hys213. Epub 2012 Dec 28.
8
Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses.随机 III 期试验：密集剂量甲氨蝶呤、长春碱、多柔比星和顺铂，或吉西他滨和顺铂作为肌层浸润性膀胱癌患者的围手术期化疗。GETUG/AFU V05 VESPER 试验次要终点分析：化疗毒性和病理反应。
Eur Urol. 2021 Feb;79(2):214-221. doi: 10.1016/j.eururo.2020.08.024. Epub 2020 Aug 28.
9
Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: a retrospective analysis from the University of Southern California.吉西他滨/顺铂新辅助化疗与甲氨蝶呤/长春碱/多柔比星/顺铂治疗肌层浸润性膀胱癌：来自南加州大学的回顾性分析。
Urol Oncol. 2013 Nov;31(8):1737-43. doi: 10.1016/j.urolonc.2012.07.005. Epub 2012 Nov 7.
10
Gemcitabine in the treatment of bladder cancer.吉西他滨治疗膀胱癌
Expert Opin Pharmacother. 2000 Mar;1(3):547-53. doi: 10.1517/14656566.1.3.547.

引用本文的文献

1
Doxorubicin Embedded into Nanofibrillated Bacterial Cellulose (NFBC) Produces a Promising Therapeutic Outcome for Peritoneally Metastatic Gastric Cancer in Mice Models via Intraperitoneal Direct Injection.嵌入纳米原纤化细菌纤维素（NFBC）的阿霉素通过腹腔直接注射对小鼠模型中的腹膜转移性胃癌产生了有前景的治疗效果。
Nanomaterials (Basel). 2021 Jun 28;11(7):1697. doi: 10.3390/nano11071697.
2
A Comprehensive Review of US FDA-Approved Immune Checkpoint Inhibitors in Urothelial Carcinoma.美国食品和药物管理局批准用于膀胱癌的免疫检查点抑制剂的全面综述。
J Immunol Res. 2017;2017:6940546. doi: 10.1155/2017/6940546. Epub 2017 Dec 10.
3
Could salvage surgery after chemotherapy have clinical impact on cancer survival of patients with metastatic urothelial carcinoma?
化疗后挽救性手术对转移性尿路上皮癌患者的癌症生存是否有临床影响？
Int J Clin Oncol. 2013 Feb;18(1):110-5. doi: 10.1007/s10147-011-0350-z. Epub 2011 Nov 18.
4
Long-term results of combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas.吉西他滨和顺铂联合化疗治疗转移性尿路上皮癌的长期结果。
Int J Clin Oncol. 2010 Aug;15(4):369-75. doi: 10.1007/s10147-010-0069-2. Epub 2010 Mar 26.
5
Complete response to FOLFOX4 therapy in a patient with advanced urothelial cancer: a case report.晚期尿路上皮癌患者接受 FOLFOX4 治疗的完全缓解：病例报告。
J Hematol Oncol. 2010 Jan 20;3:4. doi: 10.1186/1756-8722-3-4.
6
Gemcitabine and cisplatin for advanced urothelial carcinomas: the Ehime University Hospital experience.吉西他滨和顺铂治疗晚期尿路上皮癌：爱媛大学医院的经验
Int J Clin Oncol. 2007 Aug;12(4):279-83. doi: 10.1007/s10147-007-0678-6. Epub 2007 Aug 20.
7
Paclitaxel with cisplatin as salvage treatment for patients with previously treated advanced transitional cell carcinoma of the urothelial tract.以紫杉醇联合顺铂作为挽救治疗方案用于既往接受过治疗的晚期尿路上皮移行细胞癌患者。
Neoplasia. 2007 Jan;9(1):18-22. doi: 10.1593/neo.06661.
8
Piritrexim in advanced, refractory carcinoma of the urothelium (E3896): a phase II trial of the Eastern Cooperative Oncology Group.
Invest New Drugs. 2002 Nov;20(4):425-9. doi: 10.1023/a:1020675017737.
9
In vitro investigations of new therapeutic agents on bladder tumor cell lines.新型治疗药物对膀胱肿瘤细胞系的体外研究。
Urol Res. 1997;25(4):247-50. doi: 10.1007/BF00942093.
10
Phase II trial of oral piritrexim in advanced, previously treated transitional cell cancer of bladder.口服匹立昔明治疗晚期、既往接受过治疗的膀胱移行细胞癌的II期试验。
Invest New Drugs. 1997;15(2):157-63. doi: 10.1023/a:1005860806635.